CD8A and neoplasm: Importantly, when the reduced IL-2 levels were overridden by supplementation with murine recombinant IL-2, the difference in IFN production by WT and Gsdmd–/– CD8+ TILs was diminished, which was associated with the comparable tumor growth between the two groups (Figure 4, I and J).